Network
Advancing Clinical Trials in Neonatal Opioid Withdrawal (ACT NOW) Program
Total Trials
3
Recruiting
0
Active
2
Completed
1
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 5/100
Failure Rate
0.0%
0 terminated/withdrawn out of 3 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
200%
2 of 1 completed trials have results
Key Signals
2 with results
Enrollment Performance
Analytics
N/A
1(50.0%)
Phase 3
1(50.0%)
2Total
N/A(1)
Phase 3(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (3)
Showing 3 of 3 trials
NCT04214834Phase 3Active Not Recruiting
Trial to Shorten Pharmacologic Treatment of Newborns With Neonatal Opioid Withdrawal Syndrome (NOWS)
Role: lead
NCT04057820Not ApplicableCompleted
Eating, Sleeping, Consoling for Neonatal Withdrawal (ESC-NOW): a Function-Based Assessment and Management Approach
Role: lead
NCT04149509Active Not Recruiting
ACT NOW Longitudinal Study: Outcomes of Babies With Opioid Exposure Study
Role: lead
All 3 trials loaded